Lin, Y., Chen, X., Lin, Z. and Yan, W. 2022. Dexmedetomidine alleviates high glucose-induced podocyte damage by inhibiting EDA2R. Tropical Journal of Pharmaceutical Research. 21, 9 (Oct. 2022), 1885–1891. DOI:https://doi.org/10.4314/tjpr.v21i9.11.